ID   MSK-QLL2
AC   CVCL_6991
SY   MSK QLL2; MSKQLL2
DR   cancercelllines; CVCL_6991
DR   IARC_TP53; 3552
DR   Wikidata; Q54906860
RX   PubMed=7927946;
RX   PubMed=11389082;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=7927946).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=7927946; DOI=10.1002/ijc.2910590316;
RA   Xu L., Davidson B.J., Murty V.V.V.S., Li R.-G., Sacks P.G.,
RA   Garin-Chesa P., Schantz S.P., Chaganti R.S.K.;
RT   "TP53 gene mutations and CCND1 gene amplification in head and neck
RT   squamous cell carcinoma cell lines.";
RL   Int. J. Cancer 59:383-387(1994).
//
RX   PubMed=11389082;
RA   Singh B., Gogineni S.K., Sacks P.G., Shaha A.R., Shah J.P.,
RA   Stoffel A., Rao P.H.;
RT   "Molecular cytogenetic characterization of head and neck squamous cell
RT   carcinoma and refinement of 3q amplification.";
RL   Cancer Res. 61:4506-4513(2001).
//